|
52 |
Designing facility monitoring systems for cleanrooms
|
sureAssist |
2024-12-26 |
545 |
|
51 |
Proving it’s Clean with Analytics
|
sureAssist |
2024-12-26 |
693 |
|
50 |
Fda finalizes guidance to limit us of benzene in drug products
|
sureAssist |
2024-12-26 |
535 |
|
49 |
European regulators prepare for AI in pharma
|
sureAssist |
2024-12-26 |
532 |
|
48 |
what’s wrong with annex 1
|
sureAssist |
2024-12-26 |
687 |
|
47 |
FDA ramps up monitoring in high-risk areas following DEG-contamination deaths overseas
|
sureAssist |
2024-12-26 |
565 |
|
46 |
Use of new ISO 14644-17 cleanroom standard in contamination control
|
sureAssist |
2024-12-26 |
497 |
|
45 |
Singapore, Korea become WHO-listed regulatory authorities
|
sureAssist |
2024-12-26 |
508 |
|
44 |
FDA Seeks Comment on Quality Considerations for Topical Ophthalmic Drug Products Draft Guidance
|
sureAssist |
2024-12-26 |
489 |
|
43 |
FDA addresses use of remote interactive evaluations in post-pandemic era
|
sureAssist |
2024-12-26 |
503 |
